Response to chronic leukapheresis procedures and survival of chronic myelogenous leukemia patients
- 8 July 1982
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 22 (4) , 305-307
- https://doi.org/10.1046/j.1537-2995.1982.22482251215.x
Abstract
Cytoreduction of leukemic leukocytosis by continuous flow centrifugation was used in an intermittent or intensive schedule as primary therapy for an average of 16 mo. for the management of 15 patients with chronic myelogenous leukemia. The clinical response and subsequent survival of the patients was studied. Hematologic and chemical changes related to the procedures and the multiple infusions of the sedimenting agent, hydroxyethyl starch, were also studied. This mode of primary therapy offered no survival advantages to patients. There were no adverse effects of the repeated use of the sedimenting agent observed.This publication has 5 references indexed in Scilit:
- Increased Granulocyte Collection with the Blood Cell Separator and the Addition of Etiocholanolone and Hydroxyethyl StarchTransfusion, 1974
- Hydroxyethyl Starch and Dexamethasone as an Adjunct to Leukocyte Separation with the IBM Blood Cell SeparatorTransfusion, 1974
- Biological Effects of Repeated Leukapheresis of Patients With Chronic Myelogenous LeukemiaBlood, 1973
- Survival in chronic myelogenous leukemia: Influence of treatment and extent of disease at diagnosisCancer, 1973
- Repeated Leukapheresis of Patients with Chronic Myelocytic LeukemiaTransfusion, 1966